[Inhaled loxapine for emergency treatment of agitated patients with borderline personality disorder : A series of five cases].

[1]  M. Wollmer,et al.  The Hamburg-Hannover Agitation Scale (H2A): Development and validation of a self-assessment tool for symptoms of agitation. , 2015, Journal of psychiatric research.

[2]  G. Juckel,et al.  [Acute agitation conditions]. , 2015, Der Nervenarzt.

[3]  M. Müller,et al.  Pharmakotherapie von psychiatrischen Akut- und Notfallsituationen , 2015, Der Nervenarzt.

[4]  E. Meltzer,et al.  Safety and tolerability of inhaled loxapine in subjects with asthma and chronic obstructive pulmonary disease--two randomized controlled trials. , 2014, Journal of aerosol medicine and pulmonary drug delivery.

[5]  L. Salvador-Carulla,et al.  Cost of borderline personality disorder in Catalonia (Spain) , 2014, European Psychiatry.

[6]  P. Marschall,et al.  Societal cost-of-illness in patients with borderline personality disorder one year before, during and after dialectical behavior therapy in routine outpatient care. , 2014, Behaviour research and therapy.

[7]  G. Fitzmaurice,et al.  Pro Re Nata (As Needed) Psychotropic Medication Use in Patients With Borderline Personality Disorder and Subjects With Other Personality Disorders Over 14 Years of Prospective Follow-Up , 2014, Journal of clinical psychopharmacology.

[8]  K. Lieb,et al.  Pharmacotherapy for Borderline Personality Disorder—Current Evidence and Recent Trends , 2014, Current Psychiatry Reports.

[9]  M. Mimura,et al.  Absence of evidence that the pro re nata regimen confers benefit: a review of the studies , 2013, International clinical psychopharmacology.

[10]  G. Juckel.  [Inhalative loxapine: old tried and trusted medication with new indications]. , 2013, Der Nervenarzt.

[11]  J. Kehne,et al.  Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo‐controlled clinical trial with inhaled loxapine , 2012, Bipolar disorders.

[12]  G. Currier,et al.  The Psychopharmacology of Agitation: Consensus Statement of the American Association for Emergency Psychiatry Project BETA Psychopharmacology Workgroup , 2012, The western journal of emergency medicine.

[13]  D. Spyker,et al.  Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial. , 2011, The Journal of clinical psychiatry.

[14]  J. Guelfi,et al.  Personnalité borderline, automutilations et suicide : revue de la littérature , 2008 .

[15]  T. Gallarda,et al.  [Paradoxical aggressive reactions to benzodiazepine use: a review]. , 2008, L'Encephale.

[16]  S. Marder.  A review of agitation in mental illness: treatment guidelines and current therapies. , 2006, The Journal of clinical psychiatry.

[17]  V. Pérez,et al.  Injectable Atypical Antipsychotics for Agitation in Borderline Personality Disorder , 2006, Pharmacopsychiatry.

[18]  G. Currier,et al.  The expert consensus guideline series. Treatment of behavioral emergencies 2005. , 2005, Journal of psychiatric practice.

[19]  M. Allen,et al.  What Do Consumers Say They Want and Need During a Psychiatric Emergency? , 2003, Journal of psychiatric practice.

[20]  Gardner Dl,et al.  Alprazolam-induced dyscontrol in borderline personality disorder. , 1985 .